Moderna Says Trial Suggests Redesigned Vaccines Shield Towards Variants

Moderna announced preliminary results Tuesday from its examine of a coronavirus vaccine meant to guard in opposition to variants, saying the findings present it could actually design a vaccine that gives higher, longer-lasting safety than its preliminary product. However the firm mentioned it was additionally testing one other model of the vaccine that it anticipated